Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM159PT
TNBC
Basal B
Selumetinib
MEK
MAPK
11057.155
uM
54.25520
19.05870
0.4787 0.0885 0.1862 0.2584
0.9646
4.1614
SUM159PT
TNBC
Basal B
PD184352
MEK
MAPK
11057.155
uM
20.13750
999.99970
0.4189 -0.5412 0.1878 0.2397
0.9353
4.1614
SUM159PT
TNBC
Basal B
PD184352
MEK
MAPK
11057.155
uM
20.13750
999.99970
0.4189 -0.5412 0.1878 0.2397
0.9353
4.1614
SUM159PT
TNBC
Basal B
Dactolisib
PI3K
PI3K
11057.155
uM
0.06495
0.04736
0.1337 0.1744 1.3579 0.4633
0.9158
4.1614
SUM159PT
TNBC
Basal B
Trametinib
MEK
MAPK
7920.05
uM
inf
0.02034
0.4715 0.5077 0.6584 0.2518
0.9823
4.1624
SUM159PT
TNBC
Basal B
17-AAG
HSP90
HSP90
7920.05
uM
0.06950
0.07046
-0.1466 -0.0220 3.1217 0.5658
0.9871
4.1624
SUM159PT
TNBC
Basal B
ICRF-193
TOP2
TOP
11057.151
uM
1.55590
0.41918
0.3947 0.3852 1.1222 0.2144
0.9948
4.1698
SUM159PT
TNBC
Basal B
XRP44X
ELK3
MAPK
11057.151
uM
0.93403
0.78279
0.1565 0.2344 3.5803 0.3103
0.9477
4.1698
SUM159PT
TNBC
Basal B
Gefitinib
EGFR
ErbB
7920.016
uM
27.5070
43.54760
0.3380 -0.8378 2.1423 0.0270
0.9777
4.3230
SUM159PT
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7920.016
uM
inf
147.84710
0.8503 0.7670 4.7960 -0.0230
0.6294
4.3230
SUM159PT
TNBC
Basal B
AG1478
EGFR
ErbB
7920.016
uM
25.90870
33.39040
-0.2225 -0.2898 1.8023 0.1605
0.9971
4.3230
SUM159PT
TNBC
Basal B
Sirolimus
MTOR
MTOR
7920.068
uM
4.68180
9.92620
-0.2346 -0.1745 0.3983 0.3470
0.6243
4.3418
SUM159PT
TNBC
Basal B
Vinorelbine
TUBB
TUBB
7920.018
uM
0.01993
0.02096
-0.2847 -0.0483 1.8288 0.6036
0.9631
4.3723
SUM159PT
TNBC
Basal B
CGC-11047
Polyamine analogue
7920.018
uM
640.18180
1000.00000
-0.3159 -0.3141 1.0931 0.2051
0.8249
4.3723
SUM159PT
TNBC
Basal B
Cetuximab
EGFR
ErbB
7920.018
uM
inf
inf
0.9492 0.9492 0.0000 0.0108
0.4781
4.3723
SUM159PT
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
7920.13
uM
6.34610
9.52020
-0.3684 -0.3475 1.3011 0.3473
0.9952
4.3955
SUM159PT
TNBC
Basal B
5-FU
TYMS
TYMS
7920.13
uM
130.24210
83.00670
0.1415 0.1407 0.7336 0.3613
0.9971
4.3955
SUM159PT
TNBC
Basal B
GSK461364
PLK1
PLK
7920.001
uM
0.03320
0.02904
0.0820 0.0724 1.1683 0.5004
0.9949
4.4085
SUM159PT
TNBC
Basal B
GSK1070916
AURK
AURK
7920.001
uM
7.60870
32.44490
-0.0516 -1.0000 0.7575 0.1691
0.9522
4.4085
SUM159PT
TNBC
Basal B
GSK923295
CENPE
Kinesin
7920.001
uM
0.04495
0.03755
0.0271 0.2029 2.8919 0.4024
0.9647
4.4085
SUM159PT
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
7920.075
uM
9.39680
19.30080
-0.2022 -0.3465 0.7314 0.3790
0.9828
4.5785
SUM159PT
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
7920.075
uM
0.03294
0.03077
0.0327 0.0670 2.1177 0.7312
0.9949
4.5785
SUM159PT
TNBC
Basal B
Carboplatin
DNA cross-linker
DNA cross-linker
7920.075
uM
70.40610
84.95560
-0.2887 -0.2931 2.4562 0.2851
0.9991
4.5785